Drug from genetically engineered goats a first
FDA weighs approval of anti-clotting drug from milk of genetically engineered goats
Ricardo Alonso-Zaldivar, Associated Press Writer
Wednesday January 7, 2009, 11:02 am EST
Yahoo! Buzz Print Related:GTC Biotherapeutics, Inc.
WASHINGTON (AP) -- In a scientific first, an anti-clotting drug made from the milk of genetically engineered goats is moving closer to government approval for humans.
Related Quotes
Symbol Price Change
GTCB 0.7000 +0.1301
{"s" : "gtcb","k" : "c10,l10,p20,t10","o" : "","j" : ""} An evaluation by the Food and Drug Administration released Wednesday says the medication works and its safety is acceptable.
Called ATryn, the drug is intended to help people with a rare hereditary disorder that makes them vulnerable to life-threatening blood clots.
Its approval would be a major step toward new kinds of medications made not from chemicals, but from living organisms genetically manipulated by scientists. Similar drugs could be available in the next few years for a range of human ailments, including hemophilia.
ATryn is made by Massachusetts-based GTC Biotherapeutics.